About the FACT team
A dedicated Board of Directors and core headquarters team supports FACT's essential mission to assure quality and safety in cellular therapy.
Board of Directors
FACT is led by experts in cellular therapy and transplantation, governed by a 17-member Board that sets policy, establishes standards, approves accreditation, and reviews committee reports.
The Board of Directors includes:
|
|
Members of the Board
Navneet S. Majhail, MD, MBBS, MS Nadim Mahmud, MD, PhD, MBA Catherine Bollard, MBChB, MD, FRACP, FRCPA Alan Balch, PhD Wanxing Cui, MD, PhD Mary Grable McLeod, MT(ASCP) Joseph McGuirk, DO, FACP David Schmahl Phyllis I. Warkentin, MD, FASTCT | Phillip Johnson, MMedSc(Path) Hien Liu, MD Nicole Aqui, MD Rachel Cook, MD, MS Sergio Giralt, MD Patrick Hanley, PhD Eneida Nemecek, MD Nicole Lesley Prokopishyn, PhD |
Committees
FACT committees conduct the activities directed by the Board of Directors, provide consensus-based input, and implement peer-developed requirements. Committee chairs and members are appointed by the Board of Directors.
Standing Committees
Accreditation Committees
Cellular Therapy Accreditation Committee
Cord Blood Accreditation Committee
Cellular Therapy Standards Committee
Clinical Program Standards
Collection Facility Standards
Processing Facility Standards
Quality Management Standards
Immune Effector Cell Standards
Steering Committee
Cord Blood Bank Standards Committee
QM and Operational Standards
Collection Standards
Processing, Selection, and Release Standards
Steering Committee
Common Standards Steering Committee
Additional Committees
Education Committee
Executive Committee
Finance Committee
Grievance Committee
Leadership and Nominations Committee
Special Committees
Clinical Outcomes Improvement Committee
FACT-CIBMTR Data Audit Committee
Immune Effector Cell Task Force
Inspector Development Committee
Professional Relations Committee
Quality Management Committee
FACT Staff
The FACT Headquarters team can be reached at the addresses below or at fact@factglobal.org.
Executive
The executive staff manages the operations of FACT under the direction of the Board of Directors. They are responsible for the development of business objectives and policies, funding and strategic short- and long-range plans for operations, and matters related to personnel, finances, and growth.
|
|
David Schmahl
Phyllis I. Warkentin, MD, FASTCT
Suzanne Birnley, MS, MBA
Linda Miller, MPA
Joseph Schwartz, MD, MPH
Kara Wacker, MBA, RACBusiness Administration
|
|
Jay Ann Witt
Nicole Gallardo, CPM, SHRM-CPStandards Development
|
|
Monique Summers-Currington,
Erika OddyAccreditation Services
|
|
Sarah Litel-Smith, BSMT (ASCP)
Adria McCallie, CHES
Lauren Capone, RN, BMTCN
Lisa LaBrie, BSN, RN, OCN
Roberta Parrott 
Jill Siebers 
Magaly Unruh, MT(ASCP)
Meghan Quinn, MS
Nancy Schulte, MA-CCT
Stacy Freeburg
Gino Liu, MS 
Shawn Phillips
Katie SpearEducation
|
|
Jamie Price, MS, BA
Kevin Paul
Breann Weishaar
Inspector Services
|
Janice DonoghueQuality Management
|
|
Heather Conway, CQA(ASQ)
Elizabeth Jolley
Technology Services
|
Allison Miller
FACT Consulting
|
Federico Rodriguez, BSMT, SBB (ASCP)
FACT institutional partners
ISCT is a global association driving the translation of scientific research to deliver innovative cellular therapies to patients. Since 1992, ISCT has been the leading global forum for developing and supporting innovative cellular therapies through communication, education, and training.
ASTCT is an international professional association that promotes the advancement of the blood and marrow transplantation field. ASTCT members are both in clinical practice and in research.
